The Second Pediatric Blood and Marrow Transplant Consortium International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Defining the Unique Late Effects of Children Undergoing Hematopoietic Cell Transplantation for Immune Deficiencies, Inherited Marrow Failure Disorders, and Hemoglobinopathies

Andrew C. Dietz, Christine N. Duncan, Blanche P. Alter, Dorine Bresters, Morton J. Cowan, Luigi Notarangelo, Philip S. Rosenberg, Shalini Shenoy, Roderick Skinner, Mark C. Walters, John Wagner, K. Scott Baker, Michael A. Pulsipher

Research output: Contribution to journalArticle

Abstract

An international consensus conference sponsored by the Pediatric Blood and Marrow Transplant consortium entitled “Late Effects Screening and Recommendations Following Allogeneic Hematopoietic Cell Transplant for Immune Deficiency and Nonmalignant Hematologic Disease” was held in Minneapolis, Minnesota on May 10, 2016 and May 11, 2016. The purpose of the conference was to address the unmet need for greater understanding of and the screening for long-term complications in the growing population of survivors of transplantation for nonmalignant disorders. The conference focused on transplantation for hemoglobinopathy, immune deficiency, and inherited bone marrow syndromes. A multidisciplinary group of experts in the disease areas and transplantation late effects presented the current state of understanding of how the underlying disease, pretransplantation therapies, and transplantation-related factors uniquely interact to influence the development of late toxicities. Recommendations were put forth by the group for the late effects screening of survivors of transplantation for these nonmalignant disorders. The findings and recommendations that came from this conference will be presented in a series of 6 additional manuscripts in the upcoming months. In this manuscript, we explore the need for screening practices specific to the survivors of transplantation for nonmalignant diseases and the methodologic challenges associated with the study of these patients.

Original languageEnglish (US)
Pages (from-to)24-29
Number of pages6
JournalBiology of Blood and Marrow Transplantation
Volume23
Issue number1
DOIs
StatePublished - Jan 1 2017
Externally publishedYes

Fingerprint

Hemoglobinopathies
Cell Transplantation
Transplantation
Bone Marrow
Pediatrics
Transplants
Survivors
Manuscripts
Hematologic Diseases
Population

Keywords

  • Hemoglobinopathies
  • Immune deficiencies
  • Late effects
  • Marrow failure disorders
  • Pediatric allogeneic bone marrow transplantation

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

The Second Pediatric Blood and Marrow Transplant Consortium International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation : Defining the Unique Late Effects of Children Undergoing Hematopoietic Cell Transplantation for Immune Deficiencies, Inherited Marrow Failure Disorders, and Hemoglobinopathies. / Dietz, Andrew C.; Duncan, Christine N.; Alter, Blanche P.; Bresters, Dorine; Cowan, Morton J.; Notarangelo, Luigi; Rosenberg, Philip S.; Shenoy, Shalini; Skinner, Roderick; Walters, Mark C.; Wagner, John; Baker, K. Scott; Pulsipher, Michael A.

In: Biology of Blood and Marrow Transplantation, Vol. 23, No. 1, 01.01.2017, p. 24-29.

Research output: Contribution to journalArticle

Dietz, Andrew C. ; Duncan, Christine N. ; Alter, Blanche P. ; Bresters, Dorine ; Cowan, Morton J. ; Notarangelo, Luigi ; Rosenberg, Philip S. ; Shenoy, Shalini ; Skinner, Roderick ; Walters, Mark C. ; Wagner, John ; Baker, K. Scott ; Pulsipher, Michael A. / The Second Pediatric Blood and Marrow Transplant Consortium International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation : Defining the Unique Late Effects of Children Undergoing Hematopoietic Cell Transplantation for Immune Deficiencies, Inherited Marrow Failure Disorders, and Hemoglobinopathies. In: Biology of Blood and Marrow Transplantation. 2017 ; Vol. 23, No. 1. pp. 24-29.
@article{b6a4c033f115484cbc203b24f554e163,
title = "The Second Pediatric Blood and Marrow Transplant Consortium International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Defining the Unique Late Effects of Children Undergoing Hematopoietic Cell Transplantation for Immune Deficiencies, Inherited Marrow Failure Disorders, and Hemoglobinopathies",
abstract = "An international consensus conference sponsored by the Pediatric Blood and Marrow Transplant consortium entitled “Late Effects Screening and Recommendations Following Allogeneic Hematopoietic Cell Transplant for Immune Deficiency and Nonmalignant Hematologic Disease” was held in Minneapolis, Minnesota on May 10, 2016 and May 11, 2016. The purpose of the conference was to address the unmet need for greater understanding of and the screening for long-term complications in the growing population of survivors of transplantation for nonmalignant disorders. The conference focused on transplantation for hemoglobinopathy, immune deficiency, and inherited bone marrow syndromes. A multidisciplinary group of experts in the disease areas and transplantation late effects presented the current state of understanding of how the underlying disease, pretransplantation therapies, and transplantation-related factors uniquely interact to influence the development of late toxicities. Recommendations were put forth by the group for the late effects screening of survivors of transplantation for these nonmalignant disorders. The findings and recommendations that came from this conference will be presented in a series of 6 additional manuscripts in the upcoming months. In this manuscript, we explore the need for screening practices specific to the survivors of transplantation for nonmalignant diseases and the methodologic challenges associated with the study of these patients.",
keywords = "Hemoglobinopathies, Immune deficiencies, Late effects, Marrow failure disorders, Pediatric allogeneic bone marrow transplantation",
author = "Dietz, {Andrew C.} and Duncan, {Christine N.} and Alter, {Blanche P.} and Dorine Bresters and Cowan, {Morton J.} and Luigi Notarangelo and Rosenberg, {Philip S.} and Shalini Shenoy and Roderick Skinner and Walters, {Mark C.} and John Wagner and Baker, {K. Scott} and Pulsipher, {Michael A.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/j.bbmt.2016.10.004",
language = "English (US)",
volume = "23",
pages = "24--29",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - The Second Pediatric Blood and Marrow Transplant Consortium International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation

T2 - Defining the Unique Late Effects of Children Undergoing Hematopoietic Cell Transplantation for Immune Deficiencies, Inherited Marrow Failure Disorders, and Hemoglobinopathies

AU - Dietz, Andrew C.

AU - Duncan, Christine N.

AU - Alter, Blanche P.

AU - Bresters, Dorine

AU - Cowan, Morton J.

AU - Notarangelo, Luigi

AU - Rosenberg, Philip S.

AU - Shenoy, Shalini

AU - Skinner, Roderick

AU - Walters, Mark C.

AU - Wagner, John

AU - Baker, K. Scott

AU - Pulsipher, Michael A.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - An international consensus conference sponsored by the Pediatric Blood and Marrow Transplant consortium entitled “Late Effects Screening and Recommendations Following Allogeneic Hematopoietic Cell Transplant for Immune Deficiency and Nonmalignant Hematologic Disease” was held in Minneapolis, Minnesota on May 10, 2016 and May 11, 2016. The purpose of the conference was to address the unmet need for greater understanding of and the screening for long-term complications in the growing population of survivors of transplantation for nonmalignant disorders. The conference focused on transplantation for hemoglobinopathy, immune deficiency, and inherited bone marrow syndromes. A multidisciplinary group of experts in the disease areas and transplantation late effects presented the current state of understanding of how the underlying disease, pretransplantation therapies, and transplantation-related factors uniquely interact to influence the development of late toxicities. Recommendations were put forth by the group for the late effects screening of survivors of transplantation for these nonmalignant disorders. The findings and recommendations that came from this conference will be presented in a series of 6 additional manuscripts in the upcoming months. In this manuscript, we explore the need for screening practices specific to the survivors of transplantation for nonmalignant diseases and the methodologic challenges associated with the study of these patients.

AB - An international consensus conference sponsored by the Pediatric Blood and Marrow Transplant consortium entitled “Late Effects Screening and Recommendations Following Allogeneic Hematopoietic Cell Transplant for Immune Deficiency and Nonmalignant Hematologic Disease” was held in Minneapolis, Minnesota on May 10, 2016 and May 11, 2016. The purpose of the conference was to address the unmet need for greater understanding of and the screening for long-term complications in the growing population of survivors of transplantation for nonmalignant disorders. The conference focused on transplantation for hemoglobinopathy, immune deficiency, and inherited bone marrow syndromes. A multidisciplinary group of experts in the disease areas and transplantation late effects presented the current state of understanding of how the underlying disease, pretransplantation therapies, and transplantation-related factors uniquely interact to influence the development of late toxicities. Recommendations were put forth by the group for the late effects screening of survivors of transplantation for these nonmalignant disorders. The findings and recommendations that came from this conference will be presented in a series of 6 additional manuscripts in the upcoming months. In this manuscript, we explore the need for screening practices specific to the survivors of transplantation for nonmalignant diseases and the methodologic challenges associated with the study of these patients.

KW - Hemoglobinopathies

KW - Immune deficiencies

KW - Late effects

KW - Marrow failure disorders

KW - Pediatric allogeneic bone marrow transplantation

UR - http://www.scopus.com/inward/record.url?scp=85006325291&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006325291&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2016.10.004

DO - 10.1016/j.bbmt.2016.10.004

M3 - Article

C2 - 27737772

AN - SCOPUS:85006325291

VL - 23

SP - 24

EP - 29

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 1

ER -